Cartesian Therapeutics Inc logo

Cartesian Therapeutics Inc

1
1
NAS:RNAC (USA)  
$ 18.47 -0.88 (-4.55%) 11:08 PM EST
At Loss
P/B:
595.81
Market Cap:
$ 469.41M
Enterprise V:
$ 264.87M
Volume:
44.87K
Avg Vol (2M):
135.59K
Trade In:
Volume:
44.87K
At Loss
Avg Vol (2M):
135.59K

RNAC Stock Institutional Ownership and Insider Ownership - Cartesian Therapeutics Inc

25.41
(Mil)
Shares Outstanding
30.45%
7.28 (Mil)
Institutional Ownership
78.23%
19.88 (Mil)
Insider Ownership
62.80%
15.9571 (Mil)
Float Percentage of TSO

Short Interest History (%)

Due to a license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus’ website, except for certain Australian stocks.

Institutional Ownership History (%)

This the Institutional Ownership History of Cartesian Therapeutics Inc. Peter Lynch prefers to buy companies with low institutional ownership.
* Due to varying ownership data coverage and corporate events such as splits, the information in this section is in no way guaranteed for completeness, accuracy or in any other way.

Insider ownership (%)

This is the historical insider ownership of Cartesian Therapeutics Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.
1. Please note that our data vendor collects insider data for officers and directors from Forms 3,4,5 and amendments where they only capture direct ownership data, not indirect ownership.
* Due to varying ownership data coverage and corporate events such as splits, the information in this section is in no way guaranteed for completeness, accuracy or in any other way.

Top Direct Holders

Top Fund Holders